Julie Gannon
Investor Relations Officer
Head of Investor Relations
Earnings-call appearances
-
Vivos Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-15
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-29
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-16
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q1 FY2023 Earnings Call2023-06-08
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-30
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-22
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-16
Vivos Therapeutics, Inc. (VVOS)
-
Vivos Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-31
Vivos Therapeutics, Inc. (VVOS)